|
Status |
Public on Apr 07, 2021 |
Title |
Cancer-associated exportin-6 upregulation inhibits the transcriptional repressive and anticancer effects of nuclear profilin-1 |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
Aberrant expression of nuclear transporters and altered subcellular localization of their cargo proteins are increasingly recognized as drivers and therapeutic targets of cancer. Here, we report that exportin-6, a nuclear exporter specific for actin/profilin-1, is upregulated in a broad range of cancers and associated with poor prognosis. Exportin-6 loss triggers antitumor effects in breast cancer cells in a profilin-1-dependent fashion. Nuclear profilin-1 interacts with the Super Elongation Complex (SEC), a positive transcriptional regulator of pro-cancer genes including MYC. Exportin-6 loss, by increasing nuclear profilin-1, inhibits SEC-dependent transcription and sensitizes breast cancer cells to inhibition of BET domain proteins. Thus, exportin-6 upregulation is a previously unrecognized cancer addiction that reduces the transcriptional inhibitory and anticancer activities of nuclear profilin-1.
|
|
|
Overall design |
Duplicate results of RNA-seq using breast cancer MCF-7 cell line stably expressing exportin-6 (wild type or RNAi-resistant) and infected with shRNAs targeting firefly luciferase or exportin-6.
|
|
|
Contributor(s) |
Shao J, Mooradian A |
Citation(s) |
33596420 |
Submission date |
Jan 28, 2020 |
Last update date |
Apr 07, 2021 |
Contact name |
Jieya Shao |
Organization name |
Washington University in St. Louis
|
Street address |
660 South Euclid Ave
|
City |
Saint Louis |
ZIP/Postal code |
63110 |
Country |
USA |
|
|
Platforms (1) |
GPL24676 |
Illumina NovaSeq 6000 (Homo sapiens) |
|
Samples (8)
|
|
Relations |
BioProject |
PRJNA603508 |
SRA |
SRP245599 |